Insider Trading & SAST disclosures for Pfizer Ltd.
The latest disclosure under SEBI Prohibition of Insider Trading regulations was made by
Anil Gupta in Pfizer Ltd. where Acquisition of 25
Equity Shares done at an average price of Rs. 4200
was reported to the exchange on May 4, 2020.
The latest disclosures under SEBI SAST(Substantial Acquisition of Shares and Takeovers) Regulations, 2011 transaction was made by
Life Insurance Corporation of India in Pfizer Ltd. where Disposal of 926,730
shares done
was reported to the exchange on March 19, 2025.
Insider trades are disclosures under SEBI (Prohibition of Insider Trading) Regulations, 2015 ([Regulation 7 (2) with 6(2)] made by corporate insiders: promoters, officers, directors, employees and large shareholders who are buying and selling stock in their own companies.
| Client Name |
Client Category |
Action* |
Reported To/By Exchange |
Quantity |
Post Transaction Holding |
Traded % |
Avg. Price |
Value |
Period |
Regulation (Insider/SAST) |
Security Type |
Mode |
|
Life Insurance Corporation of India
|
Other |
Disposal |
11 Apr 2025 |
926,730 |
1,841,767
(4.02%)
|
2.02%
|
|
-
|
10 Feb 2022
18 Mar 2025 |
SAST (29(2)) |
- |
Market |
|
Life Insurance Corporation of India
|
Other |
Acquisition |
11 May 2022 |
929,638 |
2,768,497
(6.05%)
|
2.03%
|
|
-
|
24 Dec 2020
10 May 2022 |
SAST (29(1)) |
- |
Market |
|
Aditya Birla Sun Life Mutual Fund
|
Other |
Disposal |
29 Apr 2022 |
930,573 |
2,273,273
(4.96%)
|
2.03%
|
|
-
|
28 Apr 2022
28 Apr 2022 |
SAST (29(2)) |
- |
Market |
|
Life Insurance Corporation of India
|
Other |
Acquisition |
10 Mar 2021 |
48,244 |
2,307,523
(5.04%)
|
0.10%
|
|
-
|
09 Mar 2021
09 Mar 2021 |
SAST (29(1)) |
- |
Market |
|
Anil Gupta
|
Designated Person |
Acquisition |
04 May 2020 |
25 |
125
(0%)
|
0.00%
|
4200 |
105,000
|
20 Feb 2020
20 Feb 2020 |
Insider Trading |
Equity Shares |
Market Purchase |
|
Anil Gupta
|
Designated Person |
Acquisition |
04 May 2020 |
100 |
100
(0%)
|
0.00%
|
4050 |
405,000
|
17 Feb 2020
17 Feb 2020 |
Insider Trading |
Equity Shares |
Market Purchase |
|
Anil Gupta
|
Designated Person |
Disposal |
04 May 2020 |
150 |
0
(0%)
|
0.00%
|
4393.3 |
659,000
|
12 Feb 2020
12 Feb 2020 |
Insider Trading |
Equity Shares |
Market Sale |
|
Anil Gupta
|
Designated Person |
Acquisition |
04 May 2020 |
25 |
150
(0%)
|
0.00%
|
4078.0 |
101,951
|
04 Feb 2020
04 Feb 2020 |
Insider Trading |
Equity Shares |
Market Purchase |
|
Anil Gupta
|
Designated Person |
Acquisition |
04 May 2020 |
125 |
125
(0%)
|
0.00%
|
4116 |
514,500
|
03 Feb 2020
03 Feb 2020 |
Insider Trading |
Equity Shares |
Market Purchase |
|
Aditya Birla Sun Life AMC Ltd
|
Other |
Acquisition |
14 Nov 2018 |
916,053 |
3,203,846
(7%)
|
2%
|
|
-
|
02 Nov 2018
02 Nov 2018 |
SAST (29(2)) |
- |
Market |
|
Birla Sun Life Mutual Fund
|
Other |
Acquisition |
14 Feb 2017 |
1,350 |
2,287,777
(5%)
|
-
|
|
-
|
10 Feb 2017
10 Feb 2017 |
SAST (29(1)) |
- |
Market |
|
Wyeth LLC & PACs
|
Promoter |
Acquisition |
19 Dec 2014 |
5,617,707 |
5,617,707
(12.28%)
|
12.28%
|
|
-
|
17 Dec 2014
17 Dec 2014 |
SAST (29(1)) |
- |
Scheme Of Amalgamation |
|
Wyeth Holdings LLC
|
Promoter |
Acquisition |
19 Dec 2014 |
1,630,164 |
1,630,164
(3.56%)
|
3.56%
|
|
-
|
17 Dec 2014
17 Dec 2014 |
SAST (29(1)) |
- |
Scheme Of Amalgamation |
|
John Wyeth & Brother Ltd & PACs
|
Promoter |
Acquisition |
19 Dec 2014 |
882,000 |
882,000
(1.93%)
|
1.93%
|
|
-
|
17 Dec 2014
17 Dec 2014 |
SAST (29(1)) |
- |
Scheme Of Amalgamation |
|
Pfizer Investments Netherland
|
Promoter |
Acquisition |
04 Mar 2014 |
8,810,234 |
8,810,234
(29.52%)
|
29.52%
|
|
-
|
03 Mar 2014
03 Mar 2014 |
SAST (29(2)) |
- |
Inter-se Transfer |
|
Pfizer East India BV Netherland
|
Promoter |
Acquisition |
04 Mar 2014 |
18,186,334 |
18,186,334
(60.94%)
|
60.94%
|
|
-
|
03 Mar 2014
03 Mar 2014 |
SAST (29(1)) |
- |
Inter-se Transfer |
|
Pfizer East India B V
|
Other |
Acquisition |
04 Mar 2014 |
18,186,334 |
-
|
60.94%
|
|
-
|
03 Mar 2014
03 Mar 2014 |
SAST (10(6)) |
- |
- |
|
Pfizer Corporation
|
Promoter |
Acquisition |
04 Mar 2014 |
9,376,100 |
9,376,100
(31.42%)
|
31.42%
|
|
-
|
03 Mar 2014
03 Mar 2014 |
SAST (29(2)) |
- |
Inter-se Transfer |
|
Pfizer East India B V Netherlands
|
Other |
Acquisition |
24 Feb 2014 |
18,186,334 |
-
|
60.94%
|
|
-
|
28 Feb 2014
28 Feb 2014 |
SAST (10(1)(a)) |
- |
None |
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.